Ouabain treatment changes the role of endothelial factors in rat resistance arteries

European Journal of Pharmacology

Volumn 600, Issue 1-3, 2008, Pages 110-116

  Padilha, Alessandra S ^a,c   Peçanha, Franck M ^a,c   Vassallo, Dalton V ^c,d   Alonso, María J ^b   Salaices, Mercedes ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

^c FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^d Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

Endothelium; Endothelium derived hyperpolarizing factor; Hypertension; Nitric oxide; Ouabain; Prostanoid

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NITRIC OXIDE; OUABAIN; PHENYLEPHRINE; PROSTANOID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; HEART RATE; HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESISTANCE BLOOD VESSEL; VASCULAR ENDOTHELIUM; WISTAR RAT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART RATE; HYPERTENSION; MALE; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; OUABAIN; PHENYLEPHRINE; RATS; RATS, WISTAR;

EID: 55949088456     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.10.023     Document Type: Article

References (36)

1. Adeagbo A.S., Zhang X., Patel D., Joshua I.G., Wang Y., Sun X., Igbo I.N., and Oriowo M.A. Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension. J. Hypertens. 23 (2005) 1025-1036
2. Alvarez Y., Briones A.M., Balfagón G., Alonso M.J., and Salaices M. Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J. Hypertens. 23 (2005) 767-777
3. Auch-Schwelk W., and Vanhoutte P.M. Endothelium-derived contracting factor released by serotonin in the aorta of the spontaneously hypertensive rat. Am. J. Hypertens. 4 (1991) 769-772
4. 2+ stores and cell responsiveness. Am. J. Physiol. 264 (1993) 1367-1387
5. Briones A.M., Xavier F.E., Arribas S.M., Gonzalez M.C., Rossoni L.V., Alonso M.J., and Salaices M. Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats. Am. J. Physiol. Heart. Circ. Physiol. 291 (2006) 193-201
6. Di Filippo C., Filippelli A., Rinaldi B., Piegari E., Esposito F., Rossi F., and D'Amico M. Chronic peripheral ouabain treatment affects the brain endothelin system of rats. J. Hypertens. 21 (2003) 747-753
7. +-ATPase activity by nitric oxide: a cGMP-independent effect. Am. J. Physiol. 266 (1994) H2146-H2151
8. + pump activity by insulin and nitric oxide in rabbit aorta. Am. J. Physiol. 270 (1996) H1287-H1293
9. Hamlyn J.M., Hamilton B.P., and Manunta P. Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J. Hypertens. 14 (1996) 151-171
10. +)-ATPase associated with essential hypertension. Nature 300 (1982) 650-652
11. Hilgers R.H., Todd Jr. J., and Webb R.C. Regional heterogeneity in acetylcholine-induced relaxation in rat vascular bed: role of calcium-activated K+ channels. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H216-H222
12. Huang B.S., Huang X., Harmsen E., and Leenen F.H.H. Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats. Hypertension. 23 (1994) 1087-1090
13. Huang B.S., and Leenen F.H.H. Brain ouabain and angiotensin II in salt-sensitive hypertension in spontaneously hypertensive rats. Hypertension. 28 (1996) 1005-1012
14. Huang B.S., and Leenen F.H.H. Brain renin-angiotensin system and ouabain induced sympathetic hyperactivity and hypertension in Wistar rats. Hypertension. 34 (1999) 107-112
15. Kimura K., Manunta P., Hamilton B.P., and Hamlyn J.M. Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat. Hypertens. Res. 23 (2000) 67-76
16. Manunta P., Hamilton B.P., and Hamlyn J.M. Structure-activity relationship for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring. Hypertension. 37 (2001) 471-477
17. Manunta P., Rogowski A.C., Hamilton B.P., and Hamlyn J.M. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J. Hypertens. 12 (1994) 549-560
18. Marín J., and Redondo J. Vascular sodium pump: endothelial modulation and alterations in some pathological processes and aging. Pharmacol. Therap. 84 (1999) 249-271
19. Mathews W.R., DuCharme D.W., Hamlyn J.M., Harris D.W., Mandel F., Clark M.A., and Ludens J.H. Mass spectral characterization of an endogenous digitalislike factor from human plasma. Hypertension. 17 (1991) 930-935
20. Mollace V., Muscoli C., Masini E., Cuzzocrea S., and Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol. Rev. 57 (2005) 217-252
21. Mulvany M.J., and Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41 (1977) 19-26
22. Overbeck H.W., Pamnani M.B., Akera T., Brody T.M., and Haddy F.J. Depressed function of a ouabain-sensitive sodium-potassium pump in blood vessels from renal hypertensive dogs. Circ. Res. 38 (1976) 48-52
23. Padilha A.S., Rossoni L.V., Xavier F.E., and Vassallo D.V. Ouabain at nanomolar concentration promotes the synthesis and release of angiotensin II from the endothelium of the tail vascular bed of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 44 (2004) 372-380
24. Rossoni L.V., Cunha V., França A., and Vassallo D.V. The influence of nanomolar ouabain on vascular pressor responses is modulated by the endothelium. J. Cardiovasc. Pharmacol. 34 (1999) 887-892
25. +-ATPase activity and expression in hypertension induced by chronic administration of ouabain. Br. J Pharmacol. 135 (2002) 771-781
26. Rossoni L.V., Salaices M., Miguel M., Briones A.M., Barker L.A., Vassallo D.V., and Alonso M.J. Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. Am. J. Physiol. 283 (2002) 2110-2118
27. Salvemini D. Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol. Life Sci. 53 (1997) 576-582
28. Sanz-Rosa D., Cediel E., de las Heras N., Miana M., Balfagon G., Lahera V., and Cachofeiro V. Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NFκB/IκB system. J. Hypertens. 23 (2005) 1167-1172
29. 2. Life Sci. 80 (2006) 173-180
30. Vassallo D.V., Songu-Mize E., Rossoni L.V., and Amaral S.M. Effects of ouabain on vascular reactivity. Braz. J. Med. Biol. Res. 30 (1997) 542-552
31. +ATPase activity in the vascular smooth muscle. Blood Vessels. 15 (1978) 198-207
32. Xavier F.E., Rossoni L.V., Alonso M.J., Balfagón G., Vassallo D.V., and Salaices M. Ouabain-induced hypertension alters the participation of endothelial factors in alpha adrenergic responses differently in rat resistance and conductance mesenteric arteries. Br. J. Pharmacol. 143 (2004) 215-225
33. Xavier F.E., Yogi A., Callera G.E., Tostes R.C., Alvarez Y., Salaices M., Alonso M.J., and Rossoni L.V. Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain. Br. J. Pharmacol. 143 (2004) 794-802
34. Xie J., Wang Y., Summer W.R., and Greenberg S.S. Ouabain enhances basal release of nitric oxide from carotid artery. Am. J. Med. Sci. 305 (1993) 157-163
35. Yuan C.M., Manunta P., Hamlyn J.M., Chen S., Bohen E., Yeun J., Haddy F.J., and Pamnani M.B. Long-term ouabain administration produces hypertension in rats. Hypertension 22 (1993) 178-187
36. Zhang J., and Leenen F.H.H. AT(1) receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline. Am. J. Physiol. 280 (2001) 1318-1323